(Q42507934)

English

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

1 November 2017

Time-course of nigrostriatal damage, basal ganglia metabolic changes and behavioural alterations following intrastriatal injection of 6-hydroxydopamine in the rat: new clues from an old model (English)

1 reference

Europe PubMed Central

1 November 2017

4

object named as

Giuseppe Nappi

1 reference

Europe PubMed Central

1 November 2017

author name string

Fabio Blandini

1

1 reference

Europe PubMed Central

1 November 2017

Giovanna Levandis

2

1 reference

Europe PubMed Central

1 November 2017

Eleonora Bazzini

3

1 reference

Europe PubMed Central

1 November 2017

Marie-Therese Armentero

5

1 reference

Europe PubMed Central

1 November 2017

language of work or name

0 references

publication date

1 January 2007

1 reference

Europe PubMed Central

1 November 2017

European Journal of Neuroscience

1 reference

Europe PubMed Central

1 November 2017

25

1 reference

Europe PubMed Central

1 November 2017

397-405

1 reference

Europe PubMed Central

1 November 2017

2

1 reference

Europe PubMed Central

1 November 2017

Discriminatory roles for D1 and D2 dopamine receptor subtypes in the in vivo control of neostriatal cyclic GMP.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Dopamine receptor agonists mediate neuroprotection in malonate-induced striatal lesion in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Prolonged blockade of NMDA or mGluR5 glutamate receptors reduces nigrostriatal degeneration while inducing selective metabolic changes in the basal ganglia circuitry in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Retrograde degeneration of nigrostriatal neurons induced by intrastriatal 6-hydroxydopamine injection in rats

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Intersecting pathways to neurodegeneration in Parkinson's disease: effects of the pesticide rotenone on DJ-1, alpha-synuclein, and the ubiquitin-proteasome system

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Neuroprotective effect of rasagiline in a rodent model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Subthalamic ablation reverses changes in basal ganglia oxidative metabolism and motor response to apomorphine induced by nigrostriatal lesion in rats.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Functional changes of the basal ganglia circuitry in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Long-term behavioral and biochemical effects of 6-hydroxydopamine injections in rat caudate-putamen.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Afferent connections of the subthalamic nucleus: a combined retrograde and anterograde horseradish peroxidase study in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Neuroprotective and neurorescue effect of black tea extract in 6-hydroxydopamine-lesioned rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Primate models of movement disorders of basal ganglia origin

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Modeling Parkinson's disease in rats: an evaluation of 6-OHDA lesions of the nigrostriatal pathway

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Improved contrast in histochemical detection of cytochrome oxidase: metallic ions protocol.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Parkinson-like syndrome induced by continuous MPTP infusion: convergent roles of the ubiquitin-proteasome system and alpha-synuclein

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Neuroprotection in the rat Parkinson model by intrastriatal GDNF gene transfer using a lentiviral vector

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

The MPTP-treated mouse as a model of parkinsonism: how good is it?

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Degeneration of the nigral dopamine neurons after 6-hydroxydopamine injection into the rat striatum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Activation of caspase-3 in developmental models of programmed cell death in neurons of the substantia nigra.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Pedunculopontine nucleus in the squirrel monkey: projections to the basal ganglia as revealed by anterograde tract-tracing methods.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Evaluation of the mGluR2/3 agonist LY379268 in rodent models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Activation of p53 signaling initiates apoptotic death in a cellular model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Neural circuits and topographic organization of the basal ganglia and related regions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Critical role of ASK1 in the 6-hydroxydopamine-induced apoptosis in human neuroblastoma SH-SY5Y cells.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Ablation of the subthalamic nucleus protects dopaminergic phenotype but not cell survival in a rat model of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Differential D1 and D2 receptor-mediated effects on immediate early gene induction in a transgenic mouse model of Huntington's disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Developing a preclinical model of Parkinson's disease: a study of behaviour in rats with graded 6-OHDA lesions

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

6-hydroxydopamine-induced degeneration of the nigrostriatal dopamine pathway: the turning syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Metabolic activity of the basal ganglia in parkinsonian syndromes in human and non-human primates: a cytochrome oxidase histochemistry study.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Cytochrome oxidase: an endogenous metabolic marker for neuronal activity

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Functional anatomical and behavioral consequences of dopamine receptor stimulation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Circling behavior in rats with partial, unilateral nigro-striatal lesions: Effect of amphetamine, apomorphine, and DOPA

1 reference

https://api.crossref.org/works/10.1111%2FJ.1460-9568.2006.05285.X

21 January 2018

Identifiers

10.1111/J.1460-9568.2006.05285.X

1 reference

Europe PubMed Central

1 November 2017

1 reference

Europe PubMed Central

1 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42507934&oldid=1960152644"